• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡核苷酸和多核苷酸与甲氧基苯基功能化咪唑鎓表面活性剂的络合作用。

Complexation of Oligo- and Polynucleotides with Methoxyphenyl-Functionalized Imidazolium Surfactants.

作者信息

Kuznetsova Darya A, Kuznetsov Denis M, Vasileva Leysan A, Amerhanova Syumbelya K, Valeeva Dilyara N, Salakhieva Diana V, Nikolaeva Viktoriia A, Nizameev Irek R, Islamov Daut R, Usachev Konstantin S, Voloshina Alexandra D, Zakharova Lucia Ya

机构信息

Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Arbuzov Str. 8, 420088 Kazan, Russia.

Institute of Innovation Management, Kazan National Research Technological University, Karl Marx Str. 68, 420015 Kazan, Russia.

出版信息

Pharmaceutics. 2022 Dec 1;14(12):2685. doi: 10.3390/pharmaceutics14122685.

DOI:10.3390/pharmaceutics14122685
PMID:36559178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9782993/
Abstract

Interaction between cationic surfactants and nucleic acids attracts much attention due to the possibility of using such systems for gene delivery. Herein, the lipoplexes based on cationic surfactants with imidazolium head group bearing methoxyphenyl fragment (MPI-n, n = 10, 12, 14, 16) and nucleic acids (oligonucleotide and plasmid DNA) were explored. The complex formation was confirmed by dynamic/electrophoretic light scattering, transmission electron microscopy, fluorescence spectroscopy, circular dichroism, and gel electrophoresis. The nanosized lipoplex formation (of about 100-200 nm), contributed by electrostatic, hydrophobic interactions, and intercalation mechanism, has been shown. Significant effects of the hydrocarbon tail length of surfactant and the type of nucleic acid on their interaction was revealed. The cytotoxic effect and transfection ability of lipoplexes studied were determined using M-HeLa, A549 cancer cell lines, and normal Chang liver cells. A selective reduced cytotoxic effect of the complexes on M-HeLa cancer cells was established, as well as a high ability of the systems to be transfected into cancer cells. MPI-n/DNA complexes showed a pronounced transfection activity equal to the commercial preparation Lipofectamine 3000. Thus, it has been shown that MPI-n surfactants are effective agents for nucleic acid condensation and can be considered as potential non-viral vectors for gene delivery.

摘要

阳离子表面活性剂与核酸之间的相互作用因有可能将此类体系用于基因递送而备受关注。在此,对基于带有甲氧基苯基片段的咪唑鎓头基阳离子表面活性剂(MPI-n,n = 10、12、14、16)与核酸(寡核苷酸和质粒DNA)的脂质体复合物进行了研究。通过动态/电泳光散射、透射电子显微镜、荧光光谱、圆二色性和凝胶电泳证实了复合物的形成。已表明通过静电、疏水相互作用和嵌入机制形成了纳米级脂质体复合物(约100 - 200 nm)。揭示了表面活性剂烃链长度和核酸类型对它们相互作用的显著影响。使用M-HeLa、A549癌细胞系和正常的Chang肝细胞测定了所研究脂质体复合物的细胞毒性作用和转染能力。确定了复合物对M-HeLa癌细胞的细胞毒性作用选择性降低,以及该体系向癌细胞转染的高能力。MPI-n/DNA复合物显示出与市售制剂Lipofectamine 3000相当的显著转染活性。因此,已表明MPI-n表面活性剂是核酸凝聚的有效试剂,可被视为潜在的非病毒基因递送载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/5fd7a5b8ab61/pharmaceutics-14-02685-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/d97fc757a5b6/pharmaceutics-14-02685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/96cb82391f9b/pharmaceutics-14-02685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/67c21971869f/pharmaceutics-14-02685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/8dbc77197024/pharmaceutics-14-02685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/1be33961aaa9/pharmaceutics-14-02685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/1b76aa5691f5/pharmaceutics-14-02685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/487fce7c908b/pharmaceutics-14-02685-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/52f40034101f/pharmaceutics-14-02685-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/66f9f6b9a9c0/pharmaceutics-14-02685-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/f5d761dedd3f/pharmaceutics-14-02685-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/4d86a2f32fa2/pharmaceutics-14-02685-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/76e554ba7cf4/pharmaceutics-14-02685-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/46e0b8247078/pharmaceutics-14-02685-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/ed8bb4643137/pharmaceutics-14-02685-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/5789ad4cfa7c/pharmaceutics-14-02685-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/5fd7a5b8ab61/pharmaceutics-14-02685-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/d97fc757a5b6/pharmaceutics-14-02685-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/96cb82391f9b/pharmaceutics-14-02685-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/67c21971869f/pharmaceutics-14-02685-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/8dbc77197024/pharmaceutics-14-02685-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/1be33961aaa9/pharmaceutics-14-02685-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/1b76aa5691f5/pharmaceutics-14-02685-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/487fce7c908b/pharmaceutics-14-02685-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/52f40034101f/pharmaceutics-14-02685-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/66f9f6b9a9c0/pharmaceutics-14-02685-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/f5d761dedd3f/pharmaceutics-14-02685-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/4d86a2f32fa2/pharmaceutics-14-02685-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/76e554ba7cf4/pharmaceutics-14-02685-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/46e0b8247078/pharmaceutics-14-02685-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/ed8bb4643137/pharmaceutics-14-02685-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/5789ad4cfa7c/pharmaceutics-14-02685-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83b1/9782993/5fd7a5b8ab61/pharmaceutics-14-02685-g016.jpg

相似文献

1
Complexation of Oligo- and Polynucleotides with Methoxyphenyl-Functionalized Imidazolium Surfactants.寡核苷酸和多核苷酸与甲氧基苯基功能化咪唑鎓表面活性剂的络合作用。
Pharmaceutics. 2022 Dec 1;14(12):2685. doi: 10.3390/pharmaceutics14122685.
2
The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution.新型含脂环侧链双子表面活性剂对溶液中 DNA 结构相的影响。
Colloids Surf B Biointerfaces. 2015 Jul 1;131:83-92. doi: 10.1016/j.colsurfb.2015.04.042. Epub 2015 Apr 27.
3
Polymer-Colloid Complexes Based on Cationic Imidazolium Amphiphile, Polyacrylic Acid and DNA Decamer.基于阳离子型咪唑类两亲分子、聚丙烯酸和 DNA 十聚体的聚合物-胶体复合物。
Molecules. 2021 Apr 19;26(8):2363. doi: 10.3390/molecules26082363.
4
Gemini Surfactants Based on Bis-Imidazolium Alkoxy Derivatives as Effective Agents for Delivery of Nucleic Acids: A Structural and Spectroscopic Study.基于双咪唑鎓烷氧基衍生物的双子表面活性剂作为核酸递送的有效试剂:结构与光谱研究
PLoS One. 2015 Dec 7;10(12):e0144373. doi: 10.1371/journal.pone.0144373. eCollection 2015.
5
The Process of Binding and Releasing of Genetic Material from Lipoplexes Based on Trimeric Surfactants and Phospholipids.基于三嵌段表面活性剂和磷脂的脂质体中遗传物质的结合和释放过程。
Int J Mol Sci. 2021 Jul 20;22(14):7744. doi: 10.3390/ijms22147744.
6
A delocalizable cationic headgroup together with an oligo-oxyethylene spacer in gemini cationic lipids improves their biological activity as vectors of plasmid DNA.在双子阳离子脂质中,可离域的阳离子头基与聚氧乙烯间隔基相结合,可提高其作为质粒DNA载体的生物活性。
J Mater Chem B. 2015 Feb 28;3(8):1495-1506. doi: 10.1039/c4tb01948b. Epub 2015 Jan 22.
7
Alkyl triphenylphosphonium surfactants as nucleic acid carriers: complexation efficacy toward DNA decamers, interaction with lipid bilayers and cytotoxicity studies.烷基三苯基膦盐表面活性剂作为核酸载体:与 DNA 十聚体的络合效力、与脂质双层的相互作用及细胞毒性研究。
Phys Chem Chem Phys. 2019 Aug 14;21(30):16706-16717. doi: 10.1039/c9cp02384d. Epub 2019 Jul 19.
8
Improved in vitro gene transfer mediated by fluorinated lipoplexes in the presence of a bile salt surfactant.在胆盐表面活性剂存在下,氟化脂质体介导的体外基因转移得到改善。
J Gene Med. 2001 Jul-Aug;3(4):338-44. doi: 10.1002/jgm.188.
9
Cationic Serine-Based Gemini Surfactant:Monoolein Aggregates as Viable and Efficacious Agents for DNA Complexation and Compaction: A Cytotoxicity and Physicochemical Assessment.基于阳离子丝氨酸的双子表面活性剂:单油酸甘油酯聚集体作为用于DNA复合和压缩的可行且有效的试剂:细胞毒性和物理化学评估。
J Funct Biomater. 2024 Aug 13;15(8):224. doi: 10.3390/jfb15080224.
10
Structural studies of the formation of lipoplexes between siRNA and selected bis-imidazolium gemini surfactants.小干扰RNA(siRNA)与选定的双咪唑鎓双子表面活性剂之间脂质体复合物形成的结构研究
Colloids Surf B Biointerfaces. 2016 Oct 1;146:598-606. doi: 10.1016/j.colsurfb.2016.06.062. Epub 2016 Jun 29.

引用本文的文献

1
LncRNA16 inhibits pyroptosis and promotes platinum resistance in non-small cell lung cancer by sponging miRNA1827 to regulate MBD3/GSDME expression.长链非编码RNA16通过海绵吸附微小RNA1827以调节MBD3/GSDME的表达,从而抑制非小细胞肺癌中的细胞焦亡并促进铂耐药。
Cancer Cell Int. 2025 May 24;25(1):192. doi: 10.1186/s12935-025-03812-z.
2
Hepatoprotective Properties of New Xymedon Derivatives with a Modified Structural Moiety.具有修饰结构部分的新型乙磺半胱氨酸衍生物的肝脏保护特性
Bull Exp Biol Med. 2025 Mar;178(5):605-609. doi: 10.1007/s10517-025-06383-1. Epub 2025 Apr 28.
3
Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases.

本文引用的文献

1
Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning.肟类疗法用于有机磷中毒后脑乙酰胆碱酯酶复活及神经保护
Pharmaceutics. 2022 Sep 15;14(9):1950. doi: 10.3390/pharmaceutics14091950.
2
Enhancement of the Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Using Liposomes Containing Cationic Surfactants.使用含有阳离子表面活性剂的脂质体增强非甾体抗炎药的透皮给药
ACS Omega. 2022 Jul 12;7(29):25741-25750. doi: 10.1021/acsomega.2c03039. eCollection 2022 Jul 26.
3
Cationic Imidazolium Amphiphiles Bearing a Methoxyphenyl Fragment: Synthesis, Self-Assembly Behavior, and Antimicrobial Activity.
线粒体靶向载鱼藤酮脂质纳米粒作为治疗肿瘤疾病的新方法。
Molecules. 2023 Oct 23;28(20):7229. doi: 10.3390/molecules28207229.
4
Role of Polyanions and Surfactant Head Group in the Formation of Polymer-Colloid Nanocontainers.聚阴离子和表面活性剂头基在聚合物-胶体纳米容器形成中的作用。
Nanomaterials (Basel). 2023 Mar 16;13(6):1072. doi: 10.3390/nano13061072.
5
Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes.通过鼻内给予负载2-吡啶醛肟甲基氯化物的壳聚糖微粒治疗有机磷中毒
Pharmaceutics. 2022 Dec 19;14(12):2846. doi: 10.3390/pharmaceutics14122846.
带有甲氧基苯基片段的阳离子咪唑鎓两亲物:合成、自组装行为及抗菌活性
Langmuir. 2022 Apr 26;38(16):4921-4934. doi: 10.1021/acs.langmuir.2c00299. Epub 2022 Apr 11.
4
Self-Assembling Metallocomplexes of the Amphiphilic 1,4-Diazabicyclo[2.2.2]octane Derivative as a Platform for the Development of Nonplatinum Anticancer Drugs.两亲性1,4-二氮杂双环[2.2.2]辛烷衍生物的自组装金属配合物作为开发非铂类抗癌药物的平台
ACS Omega. 2022 Jan 14;7(3):3073-3082. doi: 10.1021/acsomega.1c06465. eCollection 2022 Jan 25.
5
Efficient DNA Condensation Induced by Chiral β-Amino Acid-Based Cationic Surfactants.手性β-氨基酸基阳离子表面活性剂诱导的高效 DNA 凝聚。
ACS Appl Bio Mater. 2021 Sep 20;4(9):7034-7043. doi: 10.1021/acsabm.1c00683. Epub 2021 Aug 25.
6
Further Studies on Cationic Gemini Amphiphiles as Carriers for Gene Delivery-The Effect of Linkers in the Structure and Other Factors Affecting the Transfection Efficacy of These Amphiphiles.阳离子 Gemini 两亲分子作为基因传递载体的进一步研究——连接体对其结构的影响以及影响这些两亲分子转染效率的其他因素
ACS Omega. 2021 Dec 1;6(49):33370-33388. doi: 10.1021/acsomega.1c03667. eCollection 2021 Dec 14.
7
Cationic gemini surfactant properties, its potential as a promising bioapplication candidate, and strategies for improving its biocompatibility: A review.阳离子双子表面活性剂的性质、作为有前途的生物应用候选物的潜力,以及提高其生物相容性的策略:综述。
Adv Colloid Interface Sci. 2022 Jan;299:102581. doi: 10.1016/j.cis.2021.102581. Epub 2021 Dec 6.
8
Controlled pVEGF delivery via a gene-activated matrix comprised of a peptide-modified non-viral vector and a nanofibrous scaffold for skin wound healing.通过由肽修饰的非病毒载体和纳米纤维支架组成的基因激活基质来控制 pVEGF 的递释,以用于皮肤创伤愈合。
Acta Biomater. 2022 Mar 1;140:149-162. doi: 10.1016/j.actbio.2021.11.037. Epub 2021 Nov 28.
9
Self-Assembling Drug Formulations with Tunable Permeability and Biodegradability.自组装药物制剂,具有可调渗透性和可生物降解性。
Molecules. 2021 Nov 10;26(22):6786. doi: 10.3390/molecules26226786.
10
Interaction of calf thymus DNA and glucose-based gemini cationic surfactants with different spacer length: A spectroscopy and DLS study.含不同间隔基的双子阳离子表面活性剂与小牛胸腺 DNA 的相互作用:光谱和 DLS 研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Feb 15;267(Pt 2):120606. doi: 10.1016/j.saa.2021.120606. Epub 2021 Nov 11.